TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17321948

Group type: EXPERIMENTAL
Intervention: 3-session intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: 1-session information session
Number of subjects: 0
Study: 15351756

Group type: EXPERIMENTAL
Intervention: Routine breastfeeding education plus peer counseling
Number of subjects: 165

Group type: COMPARATOR
Intervention: Routine breastfeeding education
Number of subjects: 165
Study: 11575344

Group type: EXPERIMENTAL
Intervention: Ropivacaine 7.5 mg ml(-1)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Bupivacaine 5 mg ml(-1)
Number of subjects: 24
Study: 9394268

Group type: EXPERIMENTAL
Intervention: Sleep disturbances
Number of subjects: 485

Group type: EXPERIMENTAL
Intervention: Gender interactions
Number of subjects: 485

Group type: EXPERIMENTAL
Intervention: Sleep disturbance and depressive symptoms relationship
Number of subjects: 485
Study: 8099639

Group type: EXPERIMENTAL
Intervention: Nasal intermittent positive pressure ventilation (NIPPV)
Number of subjects: 60
Study: 3578927

Group type: COMPARATOR
Intervention: Anti-H1 antihistamines
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Oral cromolyn
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Ketotifen
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Association of H1 and H2 anti-histamine drugs
Number of subjects: 80
Study: 30572273

Group type: EXPERIMENTAL
Intervention: Darapladib
Number of subjects: 15828

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15828
Study: 29617585

Group type: EXPERIMENTAL
Intervention: Talc slurry (4 g) administered through indwelling pleural catheter
Number of subjects: 154

Group type: COMPARATOR
Intervention: Placebo administered through indwelling pleural catheter
Number of subjects: 154
Study: 26891133

Group type: EXPERIMENTAL
Intervention: Caffeine 500 (400 mg caffeine with 500 mL water)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Water 1500 (1500 mL water)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Water 500 (500 mL water)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Cohort study (caffeine intake evaluated via questionnaires)
Number of subjects: 66
Study: 25128411

Group type: EXPERIMENTAL
Intervention: Tailored exercise and home hazard reduction program
Number of subjects: 360
Study: 22306436

Group type: EXPERIMENTAL
Intervention: Medium portion of M&M's in a small container (n=30)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Medium portion of M&M's in a large container (n=29)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Large portion of M&M's in a large container (n=29)
Number of subjects: 88
Study: 21163119

Group type: EXPERIMENTAL
Intervention: Carbohydrate-electrolyte beverage (CE)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Water
Number of subjects: 10

Group type: COMPARATOR
Intervention: Tea
Number of subjects: 10
Study: 17586130

Group type: EXPERIMENTAL
Intervention: N/EE35 (35 microg ethinyl estradiol)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: N/EE25 (25 microg ethinyl estradiol)
Number of subjects: 60
Study: 15619391

Group type: EXPERIMENTAL
Intervention: Sildenafil
Number of subjects: 132

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132
Study: 14665684

Group type: EXPERIMENTAL
Intervention: Combined (nine key presses with a temporal structure of eight intervals)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Temporal (temporal structure of Combined but performed on one key)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ordinal (ordinal structure of Combined but an isochronous rhythm)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fixed temporal and random ordinal structure; random temporal and fixed ordinal structure; random temporal and ordinal structures
Number of subjects: 0
Study: 10994884

Group type: EXPERIMENTAL
Intervention: Life Enhancement Technologies active liquid cooling vest
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Life Enhancement Technologies vest
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Steele vest
Number of subjects: 26

Group type: COMPARATOR
Intervention: Passive cooling garments
Number of subjects: 26
Study: 8631635

Group type: EXPERIMENTAL
Intervention: Dexamethasone-cyclodextrin drops (0.32% and 0.67%)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dexamethasone-cyclodextrin-polymer co-complexes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dexamethasone-cyclodextrin drops
Number of subjects: 0
Study: 1563810

Group type: EXPERIMENTAL
Intervention: Pefloxacin (400 mg b.i.d.)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Cefotaxime (1 g t.i.d.)
Number of subjects: 49
Study: 6151482

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 3837

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3837
Study: 2979218

Group type: EXPERIMENTAL
Intervention: Enprostil 70 micrograms at bedtime
Number of subjects: 102

Group type: COMPARATOR
Intervention: Ranitidine 300 mg
Number of subjects: 102
Study: 29858625

Group type: EXPERIMENTAL
Intervention: Soluble green/roasted coffee (6 g/day for 8 weeks)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control beverage (water or isotonic drink)
Number of subjects: 52
Study: 28807576

Group type: COMPARATOR
Intervention: Tidal volume of 10 mL kg−1 (G10)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Tidal volume of 12 mL kg−1 (G12)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Tidal volume of 15 mL kg−1 (G15)
Number of subjects: 36
Study: 26044075

Group type: EXPERIMENTAL
Intervention: Calcium and vitamin D supplementation (1000 mg calcium carbonate with 400 IU vitamin D daily)
Number of subjects: 34157

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34157

Group type: EXPERIMENTAL
Intervention: Calcium and vitamin D supplementation
Number of subjects: 34157
Study: 23273601

Group type: EXPERIMENTAL
Intervention: Aging individuals (20-99 years)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Alzheimer's disease (AD)
Number of subjects: 81
Study: 20974015

Group type: COMPARATOR
Intervention: Probiotic formulation (PF) consisting of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 administered for 30 days in humans
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo control group
Number of subjects: 0
Study: 18504097

Group type: EXPERIMENTAL
Intervention: Neural blockade (epidural nerve block with local anesthetic and/or opioids, neurolytic sympathetic plexus block, intrathecal nerve block with phenol)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Neural blockade
Number of subjects: 136
Study: 16502746

Group type: EXPERIMENTAL
Intervention: 20 mg methylphenidate
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 12773745

Group type: EXPERIMENTAL
Intervention: Capecitabine/docetaxel combination therapy
Number of subjects: 542

Group type: COMPARATOR
Intervention: Docetaxel monotherapy
Number of subjects: 542
Study: 10840268

Group type: EXPERIMENTAL
Intervention: APPROACH group (intervention group)
Number of subjects: 2293

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2293
Study: 9535619

Group type: EXPERIMENTAL
Intervention: Dorzolamide 2%
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 8265877

Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 2949057

Group type: EXPERIMENTAL
Intervention: 100 mg sertraline
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 200 mg sertraline
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 400 mg sertraline
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 100 mg zimelidine
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 30037660

Group type: EXPERIMENTAL
Intervention: 100 mL of 25% albumin BID for three days
Number of subjects: 46

Group type: COMPARATOR
Intervention: 0.9% saline placebo BID for three days
Number of subjects: 46
Study: 27067532

Group type: EXPERIMENTAL
Intervention: Everolimus with reduced-exposure CNI
Number of subjects: 282

Group type: COMPARATOR
Intervention: Conventional calcineurin inhibitor (CNI) therapy
Number of subjects: 282
Study: 25060610

Group type: EXPERIMENTAL
Intervention: PRN injections of 0.5 mg ranibizumab
Number of subjects: 175

Group type: COMPARATOR
Intervention: Monthly injections of 0.5 mg ranibizumab
Number of subjects: 175

Group type: COMPARATOR
Intervention: Non-randomized subjects receiving monthly injections
Number of subjects: 175
Study: 22343428

Group type: EXPERIMENTAL
Intervention: 17-week ACT program
Number of subjects: 12
Study: 20008055

Group type: EXPERIMENTAL
Intervention: Telephone-supported care coordination
Number of subjects: 525

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 525
Study: 18324952

Group type: EXPERIMENTAL
Intervention: Darifenacin alone
Number of subjects: 395

Group type: COMPARATOR
Intervention: Darifenacin + BMP
Number of subjects: 395
Study: 16042228

Group type: EXPERIMENTAL
Intervention: Glatiramer acetate (GA) treatment
Number of subjects: 0
Study: 16504579

Group type: EXPERIMENTAL
Intervention: Eplerenone 25 mg/day titrated to 50 mg/day
Number of subjects: 2106
Study: 10024335

Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Combination treatment (Enalapril + Simvastatin)
Number of subjects: 30
Study: 7571926

Group type: EXPERIMENTAL
Intervention: Cerebrolysin injected in Tenon's space
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cerebrolysin injected in retrobulbar space
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cerebrolysin injected in retrobulbar space and in combination with trental
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no cerebrolysin)
Number of subjects: 0
Study: 10147516

Group type: EXPERIMENTAL
Intervention: Chlorhexidine strips
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Metronidazole strips
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Tetracycline strips
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Root planing
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Combined root planing and metronidazole strips
Number of subjects: 69
Study: 6162599

Group type: EXPERIMENTAL
Intervention: Bleomycin (BLM) plus radiation
Number of subjects: 157

Group type: COMPARATOR
Intervention: Radiation alone (Control)
Number of subjects: 157
Study: 31955429

Group type: EXPERIMENTAL
Intervention: KE + CHO mix
Number of subjects: 5

Group type: COMPARATOR
Intervention: CHO (isocaloric CHO equivalent)
Number of subjects: 5
Study: 29906741

Group type: EXPERIMENTAL
Intervention: My-GMC (Group medical consultations combined with tablet-based online app)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Individual medical visit (care as usual)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: My-GMC
Number of subjects: 109

Group type: COMPARATOR
Intervention: Online app
Number of subjects: 109
Study: 27390976

Group type: COMPARATOR
Intervention: Bivalirudin IV bolus of 0.75 mg/kg followed by an infusion of 1.75 mg/kg/h until the end of the PCI.
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Heparin (70 UI/kg) intravenous bolus.
Number of subjects: 20
Study: 24563158

Group type: EXPERIMENTAL
Intervention: Training with direct feedback on 100 cases
Number of subjects: 31
Study: 23133602

Group type: EXPERIMENTAL
Intervention: pegylated interferon alpha (pegIFNα) 2a with ribavirin for 48 weeks
Number of subjects: 99

Group type: COMPARATOR
Intervention: pegylated interferon alpha (pegIFNα) 2b with ribavirin for 48 weeks
Number of subjects: 99
Study: 20300774

Group type: EXPERIMENTAL
Intervention: Education Group (EG) - standardized multiprofessional psycho-educational program
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: Instruction Group (IG) - structured training according to national asthma guideline
Number of subjects: 338

Group type: COMPARATOR
Intervention: Waiting Group (WG)
Number of subjects: 338
Study: 17583798

Group type: EXPERIMENTAL
Intervention: Oral insulin 7.5 mg daily
Number of subjects: 372

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 372
Study: 15208057

Group type: EXPERIMENTAL
Intervention: 5% PSS
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: 10% PSS
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: PSS vehicle
Number of subjects: 49

Group type: COMPARATOR
Intervention: Conceptrol (4% nonoxynol-9)
Number of subjects: 49
Study: 12133741

Group type: EXPERIMENTAL
Intervention: Telephone-based exercise counseling
Number of subjects: 103

Group type: COMPARATOR
Intervention: Exercise-related social support
Number of subjects: 103
Study: 9853770

Group type: EXPERIMENTAL
Intervention: Fetal gastroschisis
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (normal fetus)
Number of subjects: 10
Study: 7733478

Group type: EXPERIMENTAL
Intervention: Depogen with heparin
Number of subjects: 70

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 70
Study: 2925977

Group type: EXPERIMENTAL
Intervention: Early quit date (Week 2)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Late quit date (Week 6)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Abstinent women
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Abstinent men
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Abstinent subjects
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Caloric intake for abstinent women
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Caloric intake for abstinent men
Number of subjects: 95
Study: 30075741

Group type: EXPERIMENTAL
Intervention: Immediate chest x-ray
Number of subjects: 21

Group type: COMPARATOR
Intervention: Standard treatment according to NICE guidelines
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Not participating in the trial
Number of subjects: 21
Study: 26548854

Group type: EXPERIMENTAL
Intervention: ECG-gated high-pitch dual-source CTA
Number of subjects: 80

Group type: COMPARATOR
Intervention: Non-ECG-gated high-pitch dual-source CTA
Number of subjects: 80
Study: 24193233

Group type: COMPARATOR
Intervention: Saline solution at 5 mL/kg/h
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Saline solution at 5 mL/kg/h and dopamine 3 mg/kg/min
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Saline solution at 10 mL/kg/h
Number of subjects: 60
Study: 22576884

Group type: EXPERIMENTAL
Intervention: Tube current of ≤40 mA
Number of subjects: 80

Group type: COMPARATOR
Intervention: Mean tube current of 59 ± 20 mA
Number of subjects: 80

Group type: COMPARATOR
Intervention: Mean fluoroscopy time
Number of subjects: 80

Group type: COMPARATOR
Intervention: AP diameter
Number of subjects: 80
Study: 20233037

Group type: EXPERIMENTAL
Intervention: High-fat, saturated fatty acid (SFA)-rich meal (HFSA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-fat, monounsaturated fatty acid (MUFA)-rich meal (HFMUFA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-fat, high-complex carbohydrate with 1.24 g high oleic sunflower oil supplement (LFHCC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-fat, high-complex carbohydrate with 1.24 g long chain n-3 poly-unsaturated fatty acid (LC n-3 PUFA) supplement (LFHCCn-3)
Number of subjects: 0
Study: 18981325

Group type: EXPERIMENTAL
Intervention: lisinopril
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: atenolol
Number of subjects: 45
Study: 16097227

Group type: EXPERIMENTAL
Intervention: Asymmetric headgear (AHG)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Cervical headgear (CHG) combined with removable plate (RP)
Number of subjects: 20
Study: 12410780

Group type: EXPERIMENTAL
Intervention: Buprenorphine (up to 5 days)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Clonidine and other symptomatic medications (up to 8 days)
Number of subjects: 114
Study: 9170485

Group type: EXPERIMENTAL
Intervention: Taxicab voucher
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Baby‐blanket coupon
Number of subjects: 104

Group type: COMPARATOR
Intervention: Appointment slip (controls)
Number of subjects: 104
Study: 2036503

Group type: EXPERIMENTAL
Intervention: Health checks offered systematically to the adult population
Number of subjects: 2205
Study: 7273012

Group type: COMPARATOR
Intervention: Bolus injection of 3‐4 mg/m2 iv every 10‐14 days
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Continuous 5‐day infusion of 1‐1.2 mg/m2/day every 21 days
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Continuous infusion after failing to respond to bolus vindesine
Number of subjects: 60
Study: 31249395

Group type: EXPERIMENTAL
Intervention: High-polyphenol diet (HighP)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Low-polyphenol diet (LowP)
Number of subjects: 78
Study: 31675189

Group type: EXPERIMENTAL
Intervention: Scotchbond Universal (SU) with self-etch (SE) technique
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Prime&Bond Elect (PBE) with self-etch (SE) technique
Number of subjects: 63
Study: 27379965

Group type: EXPERIMENTAL
Intervention: Knee extension exercise in water at 90 b·min
Number of subjects: 17
Study: 25698997

Group type: EXPERIMENTAL
Intervention: Non-linguistic auditory temporal intervention
Number of subjects: 17

Group type: COMPARATOR
Intervention: Phonological intervention
Number of subjects: 17
Study: 25022119

Group type: EXPERIMENTAL
Intervention: Saturated moxa dosage group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Regular moxa dosage group
Number of subjects: 60
Study: 21351218

Group type: EXPERIMENTAL
Intervention: Project Management (PM)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 28
Study: 19440837

Group type: EXPERIMENTAL
Intervention: Think Smart curriculum (school-based drug prevention curriculum)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 17303783

Group type: EXPERIMENTAL
Intervention: Lower arm occlusion
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Upper arm occlusion
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Allopurinol (600 mg oral dose) before lower arm occlusion
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Allopurinol (600 mg oral dose) before upper arm occlusion
Number of subjects: 20
Study: 15134107

Group type: EXPERIMENTAL
Intervention: Topical 2% xylocaine jelly and 0.5 ml of intracameral 1% lidocaine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sub-Tenon infiltration with 2 ml of 2% xylocaine
Number of subjects: 100
Study: 11839347

Group type: EXPERIMENTAL
Intervention: Trained group (multimodality laparoscopic TEP hernia curriculum)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Trained group
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 21
Study: 10572845

Group type: EXPERIMENTAL
Intervention: Annual mammographic screening for women aged 40-41
Number of subjects: 195000

Group type: COMPARATOR
Intervention: Control group (no additional services offered until age 50)
Number of subjects: 195000
Study: 7884084

Group type: EXPERIMENTAL
Intervention: Thallium-201 single-photon emission computed tomography (SPECT)
Number of subjects: 321

Group type: COMPARATOR
Intervention: Exercise electrocardiographic (ECG) response
Number of subjects: 321

Group type: EXPERIMENTAL
Intervention: SPECT
Number of subjects: 321
Study: 2190630

Group type: EXPERIMENTAL
Intervention: 8 mg controlled release (CR) salbutamol tablets twice daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: 4 mg standard salbutamol tablets four times daily
Number of subjects: 0
Study: 677866

Group type: EXPERIMENTAL
Intervention: Ticarcillin plus cephalothin (T+C)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Ticarcillin plus gentamicin (T+G)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Cephalothin plus gentamicin (C+G)
Number of subjects: 105
Study: 31409292

Group type: EXPERIMENTAL
Intervention: Lasmiditan (50 mg, 100 mg, 200 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29166092

Group type: EXPERIMENTAL
Intervention: EmimNTf2 in PES membranes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DmimNTf2 in PES membranes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: C153 in bulk liquids
Number of subjects: 0
Study: 25618318

Group type: EXPERIMENTAL
Intervention: Sustained-release (SR) 75-mg tramadol/650-mg acetaminophen after a single dose
Number of subjects: 43

Group type: COMPARATOR
Intervention: Immediate release (IR) 37.5-mg tramadol/325-mg acetaminophen after 2 doses
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Sustained-release (SR) formulation with food
Number of subjects: 43

Group type: COMPARATOR
Intervention: Immediate release (IR) formulation with food
Number of subjects: 43
Study: 23355060

Group type: EXPERIMENTAL
Intervention: Digoxin
Number of subjects: 6800
Study: 21285445

Group type: EXPERIMENTAL
Intervention: Pediatric injury prevention program
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Traditional injury prevention program
Number of subjects: 65
Study: 19650753

Group type: EXPERIMENTAL
Intervention: Indacaterol 150 microg
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Indacaterol 300 microg
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Indacaterol 600 microg
Number of subjects: 45

Group type: COMPARATOR
Intervention: Formoterol 12 microg
Number of subjects: 45
Study: 17938567

Group type: EXPERIMENTAL
Intervention: Glucose in dialyzing fluid
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control (no glucose in dialyzing fluid)
Number of subjects: 44
Study: 15169807

Group type: EXPERIMENTAL
Intervention: Bevacizumab 15 mg/kg plus carboplatin and paclitaxel
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control (carboplatin and paclitaxel alone)
Number of subjects: 99
Study: 11878520

Group type: EXPERIMENTAL
Intervention: Sevoflurane anaesthesia
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Isoflurane anaesthesia
Number of subjects: 16
Study: 9766493

Group type: EXPERIMENTAL
Intervention: 9-cis retinoic acid (RA) at doses ranging from 30 to 230 mg/m2/day
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 9-cis retinoic acid (RA)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Corticosteroids
Number of subjects: 18
Study: 9266792

Group type: EXPERIMENTAL
Intervention: Consent A (non-detailed risks)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Consent B (detailed risks)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Patients without inducible ventricular arrhythmias
Number of subjects: 50
Study: 2805362

Group type: EXPERIMENTAL
Intervention: Nifedipine 10 mg sublingually
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Nifedipine 20 mg per os bid for 3 months
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15